PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patientsYoichi Nagata, Dihua Yu, Ayşegül A. Şahin et al.|Cancer Cell|2004Cited by 1.9k